Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207752 · ClinicalTrials.gov registry record · NA
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
A NA study of Meibomian Gland Dysfunction, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT01207752: Completed NA study of Meibomian Gland Dysfunction, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
NCT01207752 is a NA study of Meibomian Gland Dysfunction that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 69 participants, below the 94-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01207752, a NA study of Meibomian Gland Dysfunction, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study will be to determine the efficacy of this novel, lipid-containing artificial tear on the signs and symptoms of meibomian gland disease.
Primary Outcome
time in seconds to observer a dark spot in the tear film
Conditions Studied
Interventions
- DRUG Systane Balance
- DRUG Optive Lubricant Eye Drops
Study Locations (1)
California
- Eye Care Center - Fullerton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT01207752 record still lists
NCT01207752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 94-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (27% lower).
The record links to 1 condition, with Meibomian Gland Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Systane Balance is the first listed.
NCT01207752 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01207752 about?
NCT01207752 is a clinical study titled "The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction". The aim of this study will be to determine the efficacy of this novel, lipid-containing artificial tear on the signs and symptoms of meibomian gland disease.
What is the current status of trial NCT01207752?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2010-09. Estimated completion is 2011-07.
What conditions does trial NCT01207752 study?
This clinical trial studies the following conditions: Meibomian Gland Dysfunction.
What interventions are being tested in trial NCT01207752?
The interventions under investigation include: Systane Balance (DRUG), Optive Lubricant Eye Drops (DRUG).
Who is sponsoring clinical trial NCT01207752?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01207752 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meibomian Gland Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01207752's enrollment target sits among peer trials
69 4th of 8 higher than 5 of 8 other Meibomian Gland Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Meibomian Gland Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Meibomian Gland Dysfunction Management
ACTIVE NOT RECRUITING · NA
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
COMPLETED · NA
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
COMPLETED · NA
-
Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease
COMPLETED · NA
-
Tear Film Innovations iLux Safety Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia